Information and analysis earlier than you hear about it on CNBC and others. Declare your 1-week free trial to StreetInsider Premium here.
NEW YORK, NY / ACCESSWIRE / January 13, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $8.4 Million Comply with-On Providing for Medigus (NASDAQ: MDGS)
Medigus and its subsidiaries are centered on medical-related units and merchandise and on web and different online-related applied sciences. Medical associated actions embody miniaturized imaging tools via Scoutcam Inc. (previously generally known as Intellisense Options Inc.), modern surgical units with direct visualization capabilities for the remedy of Gastroesophageal Reflux Illness (GERD) utilizing Medigus Ultrasonic Surgical Endostapler, or MUSE, and organic gels to guard sufferers in opposition to organic threats and stop intrusion of allergens and viruses via the higher airways and eye cavities via a stake and licensing association with Polyrizon Ltd. Web-related actions embody ad-tech operations via a stake in Gix Web Ltd., f/okay/a Algomizer Ltd., or Gix, and its subsidiary, Linkury Ltd. Medigus additionally entered into agreements to accumulate stakes in Eventer Applied sciences Ltd., an internet occasion administration and ticketing platform and SmartRepairPro, an e-commerce know-how firm.
About Aegis Capital Corp.
Aegis Capital Company (“Aegis”) has been within the wealth administration and funding banking enterprise since 1984. Aegis is devoted to offering company finance, strategic advisory and associated companies to private and non-private corporations throughout a number of sectors and areas. Aegis additionally supplies analysis and gross sales and buying and selling companies to institutional buyers. Aegis provides its funding representatives a battle free service platform and is ready to present a full-range of services and products.
For extra details about this providing or Funding Banking Providers please electronic mail InvestmentBanking@aegiscap.com or name (212) 813-1010
This communication has been ready by Aegis Capital Company for distribution to Aegis Capital Company’s clientele. This communication just isn’t meant for public dissemination and the recipient is prohibited from sharing this info. This communication has been ready for institutional – accounts, as outlined inside FINRA Rule 4512(c), who (1) are able to evaluating funding dangers independently, each on the whole and with regard to all transactions and funding methods involving a safety or securities; and (2) will train unbiased judgment in evaluating the suggestions of any dealer – vendor or its related individuals. This communication just isn’t a product of Aegis Capital Company Analysis Division. Aegis Capital Company., Member FINRA, SIPC
SOURCE: Aegis Capital Corp.
View supply model on accesswire.com: